Reveal the Patterns of Prescriptions for Recurrent Respiratory Tract Infections' Treatment Based on Multiple Illustrious Senior Traditional Chinese Medicine Practitioners.


Journal

Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021

Informations de publication

Date de publication:
2023
Historique:
received: 11 07 2022
revised: 11 11 2022
accepted: 23 11 2022
medline: 5 6 2023
pubmed: 5 6 2023
entrez: 5 6 2023
Statut: epublish

Résumé

Recurrent respiratory tract infections (RRTIs) are one of the most common diseases in children and adolescents. The causes of RRTIs are various. In addition to the factors related to infection, basic diseases such as respiratory system, immune system, and digestive system are also involved. The cost of patients' frequent medical treatment and hospitalization has been deemed to be a heavy burden to the society and family. In China, traditional Chinese medicine (TCM) is commonly used to treat RRTIs. TCM treatment has been appraised to be effective, for reducing the number of hospital stays. Illustrious senior TCM practitioners of pediatrics are recognized as a group of outstanding physicians with significantly better patient outcomes. However, different illustrious senior TCM practitioners can lead to differences in treatment strategies due to factors such as region, prescription theory, and individual differences of patients. This makes it difficult for the experience of illustrious senior TCM practitioners to be popularized. However, there have been no prescription mining studies for the treatment of RRTIs based on different and multiple illustrious senior TCM practitioners. We explored the core prescriptions and drug mechanisms through data mining based on the prescriptions of illustrious senior TCM practitioners treating RRTIs from different clinical settings. This is important to promote the effective treatment of RRTIs with TCM. The objective of this study is to reveal the strategies (core prescriptions) from the prescriptions of multiple illustrious senior TCM practitioners for the treatment of RRTIs. We hope that this core prescription can help all TCM pediatricians to improve RRTIs children's outcome. Meanwhile, it could provide a new way for researchers to study the treatment of RRTIs. In this study, we prospectively collected 400 children's prescriptions with RRTIs receiving TCM treatment from four illustrious senior TCM practitioners in different hospitals. We described and analyzed the characteristics of TCM prescriptions. The prescription regularity was analyzed by hierarchical clustering and association rules. Network pharmacology methods has been used to reveal the pathway mechanism of core prescriptions which have been mined and visualized with the help of SymMap, Genecards, KEGG, Metascape databases, and According to RRTIs multiple clinical syndromes, five new prescriptions were obtained based on illustrious senior TCM practitioners. Among them, the prescription composed of In this study, we revealed the prescription regularity of TCM in the treatment of RRTIs and analyzed the mechanism of core prescriptions, which provided new ideas for the treatment of RRTIs.

Sections du résumé

Background UNASSIGNED
Recurrent respiratory tract infections (RRTIs) are one of the most common diseases in children and adolescents. The causes of RRTIs are various. In addition to the factors related to infection, basic diseases such as respiratory system, immune system, and digestive system are also involved. The cost of patients' frequent medical treatment and hospitalization has been deemed to be a heavy burden to the society and family. In China, traditional Chinese medicine (TCM) is commonly used to treat RRTIs. TCM treatment has been appraised to be effective, for reducing the number of hospital stays. Illustrious senior TCM practitioners of pediatrics are recognized as a group of outstanding physicians with significantly better patient outcomes. However, different illustrious senior TCM practitioners can lead to differences in treatment strategies due to factors such as region, prescription theory, and individual differences of patients. This makes it difficult for the experience of illustrious senior TCM practitioners to be popularized. However, there have been no prescription mining studies for the treatment of RRTIs based on different and multiple illustrious senior TCM practitioners. We explored the core prescriptions and drug mechanisms through data mining based on the prescriptions of illustrious senior TCM practitioners treating RRTIs from different clinical settings. This is important to promote the effective treatment of RRTIs with TCM. The objective of this study is to reveal the strategies (core prescriptions) from the prescriptions of multiple illustrious senior TCM practitioners for the treatment of RRTIs. We hope that this core prescription can help all TCM pediatricians to improve RRTIs children's outcome. Meanwhile, it could provide a new way for researchers to study the treatment of RRTIs.
Methods UNASSIGNED
In this study, we prospectively collected 400 children's prescriptions with RRTIs receiving TCM treatment from four illustrious senior TCM practitioners in different hospitals. We described and analyzed the characteristics of TCM prescriptions. The prescription regularity was analyzed by hierarchical clustering and association rules. Network pharmacology methods has been used to reveal the pathway mechanism of core prescriptions which have been mined and visualized with the help of SymMap, Genecards, KEGG, Metascape databases, and
Results UNASSIGNED
According to RRTIs multiple clinical syndromes, five new prescriptions were obtained based on illustrious senior TCM practitioners. Among them, the prescription composed of
Conclusion UNASSIGNED
In this study, we revealed the prescription regularity of TCM in the treatment of RRTIs and analyzed the mechanism of core prescriptions, which provided new ideas for the treatment of RRTIs.

Identifiants

pubmed: 37275574
doi: 10.1155/2023/7982927
pmc: PMC10234731
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7982927

Informations de copyright

Copyright © 2023 Bochuan Wang et al.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflicts of interest.

Références

J Pharm Biomed Anal. 2020 Sep 10;189:113410
pubmed: 32574998
Comput Struct Biotechnol J. 2020 Dec 04;19:62-71
pubmed: 33363710
Am J Chin Med. 2022;50(1):91-131
pubmed: 34931589
Zhongguo Zhong Yao Za Zhi. 2020 Apr;45(8):1942-1947
pubmed: 32489081
Nature. 2007 Jul 12;448(7150):126-8
pubmed: 17625539
Front Plant Sci. 2022 Mar 03;13:866282
pubmed: 35310641
Acta Pharmacol Sin. 2015 Jun;36(6):654-8
pubmed: 25864650
Paediatr Respir Rev. 2013 Mar;14(1):53-60
pubmed: 23347661
Sci Bull (Beijing). 2016;61(18):1391-1398
pubmed: 27730005
Plants (Basel). 2022 Apr 06;11(7):
pubmed: 35406976
Biomed Pharmacother. 2021 Jan;133:110917
pubmed: 33217688
Cell Biochem Biophys. 2015 Apr;71(3):1307-12
pubmed: 25395193
Sci Rep. 2017 Jun 6;7(1):2821
pubmed: 28588237
J Ethnopharmacol. 2012 May 7;141(1):314-21
pubmed: 22401763
J Ethnopharmacol. 2014 Mar 28;152(3):568-74
pubmed: 24548751
Zhongguo Zhong Yao Za Zhi. 2016 Jul;41(13):2428-2434
pubmed: 28905564
Phytother Res. 2016 Jul;30(7):1095-103
pubmed: 27145435
Front Pharmacol. 2021 Jan 19;11:598744
pubmed: 33542688
Pediatr Pulmonol. 2020 Jul;55(7):1567-1583
pubmed: 32364320
Clin Exp Immunol. 2012 Jan;167(1):108-19
pubmed: 22132890
Allergy. 2013 Dec;68(12):1610-3
pubmed: 24117783
BMC Infect Dis. 2014 Oct 30;14:544
pubmed: 25358423
Front Pediatr. 2021 Dec 24;9:756217
pubmed: 35004539
Medicine (Baltimore). 2021 Dec 17;100(50):e27939
pubmed: 34918642
Evid Based Complement Alternat Med. 2020 Oct 26;2020:8979713
pubmed: 33193802
J Ethnopharmacol. 2012 Apr 10;140(3):634-42
pubmed: 22322251
J Chem Inf Model. 2017 Mar 27;57(3):468-483
pubmed: 28257573

Auteurs

Bochuan Wang (B)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Jiang Zhou (J)

Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Bing He (B)

Dongzhimeng Hospital Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Huiyang Shi (H)

The Second Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.

Xue Liang (X)

Jilin Academy of Traditional Chinese Medicine, Changchun, Jilin, China.

Zhiqiang Zhang (Z)

Beijing Tcmages Pharmaceutical Co., Ltd., Beijing, China.

Changyong Luo (C)

Dongfang Hospital Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Chen Bai (C)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Yixuan Ao (Y)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

He Yu (H)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Xiaohong Gu (X)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Classifications MeSH